Abstract |
Forty female patients with urethrocystitis received sparfloxacin in a daily dose 400 mg for 20 days in combination with canefron H (50 drops three times a day for 8 weeks). Twenty patients received one more course of canefron H 4 months after etiopathogenetic therapy. The analysis of the treatment results allows the conclusion that sparfloxacin is highly effective in urethrocystitis associated with intracellular infections. Sparfloxacin provides complete urine sterility. 97.5% females after the combined treatment had no recurrences for a year while before the treatment remission lasted for 4.1 +/- 1.7 months. A preventive administration of canefron H improves microcirculation in the bladder wall and prevents recurrence in patients with urethrocystitis associated with intracellular infections given basic sparfloxacin therapy.
|
Authors | E V Kul'chavenia, A A Breusov |
Journal | Urologiia (Moscow, Russia : 1999)
(Urologiia)
2010 Jul-Aug
Issue 4
Pg. 25-9
ISSN: 1728-2985 [Print] Russia (Federation) |
PMID | 20973133
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Fluoroquinolones
- Plant Extracts
- canephron N
- sparfloxacin
|
Topics |
- Adolescent
- Adult
- Anti-Bacterial Agents
(administration & dosage, adverse effects, therapeutic use)
- Chronic Disease
- Cystitis
(complications, drug therapy, microbiology)
- Drug Therapy, Combination
- Female
- Fluoroquinolones
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Plant Extracts
(administration & dosage, adverse effects, therapeutic use)
- Treatment Outcome
- Urinary Tract Infections
(complications, drug therapy, microbiology)
- Young Adult
|